| MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis Aug 26th 2015, 14:41, by Osamu Baba, Shogo Hasegawa, Hiroki Nagai, Fumihiko Uchida, Masanobu Yamatoji, Naomi I. Kanno, Kenji Yamagata, Satoshi Sakai, Toru Yanagawa, Hiroki Bukawa BackgroundAbnormal miRNA expression was recently implicated in the metastasis of oral squamous cell carcinoma (OSCC) and with a poor prognosis. The initiation of the invasion-metastasis cascade involves epithelial-mesenchymal transition (EMT). Our aim was to clarify how miRNA, especially miR-155-5p misexpression contributes to OSCC metastasis through EMT. MethodsWe collected tumor samples from 73 subjects with OSCC. The samples were analyzed by quantitative reverse-transcription polymerase chain reaction (qRT-PCR), and correlations between miR-155-5p levels and clinical characteristics were investigated. OSCC cell lines were analyzed by miRNA microarray and by transfection with a miR-155-5p mimic or inhibitor, followed by proliferation and wound-healing migration assays. qRT-PCR analyses of EMT makers in cells transfected with miR-155-5p inhibitor were performed. ResultsWe found high miR-155-5p expression in tissue samples from subjects with OSCC that had metastasized to cervical lymph nodes. HSC-3 cells also strongly expressed miR-155-5p. The epithelial marker E-cadherin was strongly expressed in HSC-3 cells transfected with miR-155-5p inhibitor, and we observed elevated SOCS1 and decreased STAT3 expression in these cells. ConclusionsOur results suggest that miR-155-5p causes OSCC to metastasize, and could serve as a novel therapeutic target for OSCC. |
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου